Perfusion predicts six-month survival
Results from a prospective study bolster confidence that a negative adenosine perfusion contrast MR test means patients have a good chance of surviving the next six months without major heart problems.
Results from a prospective study bolster confidence that a negative adenosine perfusion contrast MR test means patients have a good chance of surviving the next six months without major heart problems.
Dr. David Hardung from St. Marien Hospital in Bonn, Germany, surveyed the medical experience of 432 patients with negative adenosine stress tests or evidence of minor perfusion deficits involving less than 25% transmural enhancement of the myocardial wall. The event-free survival rate after 267 days was 98.8%. One cardiac death was reported from nonischemic dilated cardiomyopathy. No incidences of myocardial infarction or acute coronary syndrome occurred, but four cases of significant coronary artery disease were identified among 36 patients who underwent coronary angiography in the follow-up period.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).
MRI Study Suggests Shape of White Matter Hyperintensities May Be Predictive of Cognitive Decline
April 7th 2025Emerging research demonstrated that cognitive declines in memory, executive function and processing speed domains were associated with irregular shape of periventricular/confluent white matter hyperintensities.
Can Abbreviated MRI Have an Impact in Rectal Cancer Staging?
April 4th 2025Abbreviated MRI demonstrated a 95.3 percent specificity for rectal cancer and provided strong agreement with the full MRI protocol for T staging and detection of extramural venous invasion, according to newly published research.
